Sugi Predict

Sugi Predict / Compounds / SCHEMBL6724306

SCHEMBL6724306

SCHEMBL6724306

CN(c1ccccc1-c1cccc(-c2ccccc2)c1)c1ccccc1-c1cccc(-c2ccccc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER1 P34995 1/20 0.41
▸ PTGER4 P35408 1/20 0.41
▸ PTGER3 P43115 1/20 0.41
▸ PTGER2 P43116 1/20 0.41
▸ MAOA P21397 1/20 0.39
▸ KMO O15229 1/20 0.38
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ APAF1 O14727 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ XBP1 P17861 1/20 0.37
▸ PTBP1 P26599 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ GALK1 P51570 1/20 0.37
▸ BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6723586 0.91 CHKA (0.42) PTGER1PTGER4PTGER3PTGER2MAOA
SCHEMBL6723840 0.89 CHKA (0.38) PTGER1PTGER4PTGER3PTGER2MAOA
SCHEMBL6723989 0.89 CHKA (0.38) PTGER1PTGER4PTGER3PTGER2MAOA
SCHEMBL6724024 0.89 PTGER1 (0.37) PTGER1PTGER4PTGER3PTGER2MAOA
SCHEMBL6724213 0.85 TAAR1 (0.43) MEN1KMT2ASMN1; SMN2TACR1HTR7
SCHEMBL6723948 0.85 MEN1 (0.45) MEN1KMT2ASMN1; SMN2TACR1HTR7
SCHEMBL1224114 0.83 PTGER1 (0.43) PTGER1PTGER4PTGER3PTGER2MAOA
SCHEMBL6724005 0.83 CHKA (0.39) MAOAMEN1KMT2ASMN1; SMN2APAF1
SCHEMBL21673236 0.82 ALDH1A1 (0.44) PTGER1PTGER4PTGER3PTGER2MEN1
SCHEMBL18076341 0.81 MAPT (0.47) MEN1KMT2ASMN1; SMN2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178216-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-15 — — US disclosed
US-8178216-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-15 — — US disclosed
US-20090072718-A1 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-03-19 — — US disclosed
US-20090072718-A1 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090072718-A1 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative CRY1, GRK1, CRY2 PTGER1 218/4885PTGER4 502/4885PTGER3 1354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.